CAS 186393-42-0

7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(5-deoxy-β-D-ribofuranosyl)-N-(4-fluorophenyl)-5-phenyl-

Description:

7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(5-deoxy-β-D-ribofuranosyl)-N-(4-fluorophenyl)-5-phenyl- is a complex organic compound characterized by its unique bicyclic structure that incorporates both pyrrole and pyrimidine moieties. This compound features a ribofuranosyl group, which is a sugar component that can influence its biological activity and solubility. The presence of a fluorophenyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. The compound's structure may confer specific properties such as stability, reactivity, and selectivity towards certain enzymes or receptors. Additionally, the presence of multiple aromatic rings can enhance lipophilicity, potentially affecting its pharmacokinetics. As with many compounds in this class, it may exhibit interesting biological activities, including anti-cancer or anti-viral properties, warranting further investigation in drug discovery and development. Overall, this compound exemplifies the intricate relationship between molecular structure and biological function in the realm of medicinal chemistry.

Formula: C₂₃H₂₁FN₄O₃

Synonyms:

• 7-(5-Deoxy-β-D-ribofuranosyl)-N-(4-fluorophenyl)-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• GP3269
• 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(5-deoxy-β-D-ribofuranosyl)-N-(4-fluorophenyl)-5-phenyl-

GP3269

CAS: 186393-42-0

GP3269 is a selective, potent, orally active human adenosine kinase (AK) inhibitor (IC50: 11 nM) with anticonvulsant effects in rats.

Formula: C₂₃H₂₁FN₄O₃

Color and Shape: Solid

Molecular weight: 420.44

Ref: TM-T62227